Missed GME or NVDA? Don’t Miss the Next One.​
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
LFST Stock Forecast 2025-2026
$5.49
Current Price
$2.19B
Market Cap
Buy 6
Hold 2
Sell 0
Wall St Analyst Ratings
Distance to LFST Price Targets
+82.1%
To High Target of $10.00
+54.8%
To Median Target of $8.50
+45.7%
To Low Target of $8.00
LFST Price Momentum
-6.0%
1 Week Change
-15.4%
1 Month Change
-3.7%
1 Year Change
-25.5%
Year-to-Date Change
-36.2%
From 52W High of $8.61
+18.3%
From 52W Low of $4.64
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching LifeStance (LFST) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on LFST and similar high-potential opportunities.
Latest LFST Stock Price Targets & Analyst Predictions
Based on our analysis of 10 Wall Street analysts, LFST has a bullish consensus with a median price target of $8.50 (ranging from $8.00 to $10.00). The overall analyst rating is Strong Buy (8.5/10). Currently trading at $5.49, the median forecast implies a 54.8% upside. This outlook is supported by 6 Buy, 2 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Jamie Perse at Goldman Sachs, projecting a 82.1% upside. Conversely, the most conservative target is provided by Richard Close at Canaccord Genuity, suggesting a 45.7% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
LFST Analyst Ratings
6
Buy
2
Hold
0
Sell
LFST Price Target Range
Low
$8.00
Average
$8.50
High
$10.00
Current: $5.49
Latest LFST Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for LFST.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 8, 2025 | Keybanc | Steve Dechert | Overweight | Initiates | $9.00 |
| Apr 3, 2025 | Canaccord Genuity | Richard Close | Buy | Initiates | $8.00 |
| Dec 16, 2024 | Goldman Sachs | Jamie Perse | Buy | Upgrade | $10.00 |
| Nov 11, 2024 | Barclays | Stephanie Davis | Underweight | Maintains | $7.00 |
| Aug 15, 2024 | UBS | Kevin Caliendo | Neutral | Maintains | $7.50 |
| Aug 9, 2024 | Barclays | Stephanie Davis | Underweight | Maintains | $6.00 |
| Apr 22, 2024 | Morgan Stanley | Ricky Goldwasser | Overweight | Reiterates | $10.00 |
| Mar 6, 2024 | Jefferies | Brian Tanquilut | Buy | Maintains | $9.00 |
| Mar 4, 2024 | Goldman Sachs | Jamie Perse | Neutral | Maintains | $9.00 |
| Feb 29, 2024 | Barclays | Underweight | Maintains | $8.00 | |
| Nov 22, 2023 | Goldman Sachs | Jamie Perse | Neutral | Maintains | $8.00 |
| Nov 17, 2023 | JP Morgan | Lisa Gill | Neutral | Maintains | $8.00 |
| Aug 10, 2023 | JP Morgan | Lisa Gill | Neutral | Maintains | $10.00 |
| Jul 13, 2023 | Morgan Stanley | Overweight | Reiterates | $0.00 | |
| May 19, 2023 | Goldman Sachs | Jamie Perse | Neutral | Maintains | $9.00 |
| May 11, 2023 | Morgan Stanley | Ricky Goldwasser | Overweight | Maintains | $10.00 |
| Jan 6, 2023 | Morgan Stanley | Ricky Goldwasser | Overweight | Upgrade | $8.00 |
| Nov 15, 2022 | Goldman Sachs | Jamie Perse | Neutral | Maintains | $8.00 |
| Nov 14, 2022 | Cowen & Co. | Gary Taylor | Outperform | Maintains | $8.00 |
| Nov 7, 2022 | Jefferies | Brian Tanquilut | Buy | Assumes | $0.00 |
Lifestance Health Group Inc. (LFST) Competitors
The following stocks are similar to LifeStance based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Lifestance Health Group Inc. (LFST) Financial Data
Lifestance Health Group Inc. has a market capitalization of $2.19B with a P/E ratio of -36.6x. The company generates $1.28B in trailing twelve-month revenue with a -2.8% profit margin.
Revenue growth is +10.8% quarter-over-quarter, while maintaining an operating margin of +0.5% and return on equity of -2.5%.
Valuation Metrics
Market Cap
$2.19B
Enterprise Value
$2.55B
P/E Ratio
-36.6x
PEG Ratio
-33.1x
Price/Sales
1.7x
Growth & Margins
Revenue Growth (YoY)
+10.8%
Gross Margin
+33.0%
Operating Margin
+0.5%
Net Margin
-2.8%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+6.3%
Current Ratio
1.5x
Debt/Equity
33.1x
ROE
-2.5%
ROA
-0.3%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Lifestance Health Group Inc. (LFST) Business Model
About Lifestance Health Group Inc.
What They Do
Provides comprehensive behavioral health care services.
Business Model
The company operates by connecting patients with mental health professionals, including psychiatrists and therapists, through both in-person and telehealth appointments. It collaborates with insurance providers to facilitate access to care, making its services more affordable and convenient for patients, which drives revenue through service fees and insurance reimbursements.
Additional Information
Lifestance Health is positioned in a growing market, addressing increasing demand for mental health services. Its commitment to patient-centered care and integration within the community enhances its impact and relevance in the behavioral health sector, potentially influencing mental health policies across the U.S.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
7,535
CEO
Mr. David Patrick Bourdon
Country
United States
IPO Year
2021
Website
lifestance.comLifestance Health Group Inc. (LFST) Latest News & Analysis
Latest News
Quick Summary
LifeStance Health has appointed Vaughn Paunovich as Chief Technology Officer, effective June 9, 2025, enhancing its leadership in virtual and in-person mental health care.
Why It Matters
The appointment of Vaughn Paunovich as CTO may enhance LifeStance Health's technology strategy, potentially improving service delivery and competitive positioning in the mental health market.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
LifeStance Health Group, Inc. (NASDAQ: LFST) will hold its Q1 2025 results conference call on May 7, 2025, at 8:30 AM ET, featuring executives including CEO David Bourdon.
Why It Matters
The upcoming Q1 2025 results call for LifeStance Health may reveal financial performance and strategic direction, influencing stock valuation and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
LifeStance Health (LFST) has received a Zacks Rank #1 (Strong Buy) upgrade, indicating increased optimism about its earnings prospects, potentially boosting the stock price.
Why It Matters
LifeStance Health's upgrade to a Strong Buy signals increased confidence in its earnings potential, likely leading to a stock price increase and attracting more investor interest.
Source: Zacks Investment Research
Market Sentiment:
Positive
Down -20.26% in 4 Weeks, Here's Why LifeStance Health (LFST) Looks Ripe for a Turnaround
15 days ago
Quick Summary
LifeStance Health (LFST) is currently oversold, suggesting reduced selling pressure. Analysts are raising earnings estimates, indicating a potential trend reversal for the stock.
Why It Matters
LifeStance Health (LFST) being oversold suggests a rebound may occur soon, while rising earnings estimates from analysts indicate improved future performance, signaling a buying opportunity.
Source: Zacks Investment Research
Market Sentiment:
Positive
LifeStance Reports First Quarter 2025 Results
17 days ago
Quick Summary
LifeStance Health Group, Inc. (Nasdaq: LFST) reported its financial results for Q1 2025, ending March 31, as one of the largest outpatient mental healthcare providers in the U.S.
Why It Matters
LifeStance Health's Q1 financial results indicate its performance and growth potential, influencing stock valuation and investor sentiment in the mental healthcare sector.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
LifeStance Health Group (LFST) reported break-even earnings per share this quarter, outperforming the Zacks Consensus Estimate of a $0.04 loss and improving from a loss of $0.06 per share a year ago.
Why It Matters
LifeStance Health Group's break-even earnings exceed expectations, signaling potential operational improvement and increased investor confidence, which may positively impact stock performance.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Frequently Asked Questions About LFST Stock
What is Lifestance Health Group Inc.'s (LFST) stock forecast for 2025?
Based on our analysis of 10 Wall Street analysts, Lifestance Health Group Inc. (LFST) has a median price target of $8.50. The highest price target is $10.00 and the lowest is $8.00.
Is LFST stock a good investment in 2025?
According to current analyst ratings, LFST has 6 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $5.49. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for LFST stock?
Wall Street analysts predict LFST stock could reach $8.50 in the next 12 months. This represents a 54.8% increase from the current price of $5.49. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Lifestance Health Group Inc.'s business model?
The company operates by connecting patients with mental health professionals, including psychiatrists and therapists, through both in-person and telehealth appointments. It collaborates with insurance providers to facilitate access to care, making its services more affordable and convenient for patients, which drives revenue through service fees and insurance reimbursements.
What is the highest forecasted price for LFST Lifestance Health Group Inc.?
The highest price target for LFST is $10.00 from Jamie Perse at Goldman Sachs, which represents a 82.1% increase from the current price of $5.49.
What is the lowest forecasted price for LFST Lifestance Health Group Inc.?
The lowest price target for LFST is $8.00 from Richard Close at Canaccord Genuity, which represents a 45.7% increase from the current price of $5.49.
What is the overall LFST consensus from analysts for Lifestance Health Group Inc.?
The overall analyst consensus for LFST is bullish. Out of 10 Wall Street analysts, 6 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $8.50.
How accurate are LFST stock price projections?
Stock price projections, including those for Lifestance Health Group Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 24, 2025 9:06 AM UTC